MLYS vs OPK: stock comparison and AI forecast
Mineralys Therapeutics, Inc. (MLYS) and Opko Health, Inc. (OPK) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MLYS Mineralys Therapeutics, Inc.
- Market Cap
- $1.35B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
OPK Opko Health, Inc.
- Price
- $1.77 +58.0% · 6M
- Market Cap
- $1.31B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MLYS and OPK have similar market capitalizations ($1.35B and $1.31B).
- OPK carries 0.68 times debt per unit of equity, against 0.25 times for MLYS.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MLYS | OPK |
|---|---|---|
| Market Cap | $1.35B | $1.31B |
| P/B Ratio | 2.67x | 1.17x |
| EPS | $-4.60 | $-0.40 |
| Book Value/Share | $5.70 | $1.50 |
| Revenue/Share | – | $0.86 |
| FCF/Share | – | $-0.18 |
Profitability & Margins
| Metric | MLYS | OPK |
|---|---|---|
| ROE | -73.4% | -23.0% |
| ROA | -58.7% | -13.6% |
| ROIC | -67.5% | -7.4% |
| Gross Margin | – | 57.7% |
| Operating Margin | – | -24.8% |
| Net Margin | – | -49.8% |
| EBT Margin | – | -46.1% |
| Tax Rate | – | 14.3% |
Financial Health
| Metric | MLYS | OPK |
|---|---|---|
| Current Ratio | 11.83x | 4.97x |
| Quick Ratio | – | 4.65x |
| D/E Ratio | 0.25x | 0.68x |
| Financial Leverage | 1.25x | 1.68x |
| Interest Coverage | – | -1.9x |
| Working Capital | $575M | $644M |
Cash Flow
| Metric | MLYS | OPK |
|---|---|---|
| Operating Cash Flow | -$153M | -$125M |
| Free Cash Flow | – | -$135M |
| Capital Spending | – | -$10M |
| FCF/Sales | – | -21.2% |
| CapEx/Sales | – | 1.6% |
Operational Efficiency
| Metric | MLYS | OPK |
|---|---|---|
| Asset Turnover | – | 0.34x |
| Receivables Turnover | – | 8.0x |
| Inventory Turnover | – | 5.3x |
| Fixed Assets Turnover | – | 9.4x |
| Days Sales Outstanding | – | 46 days |
| Days Inventory | – | 68 days |
| Payables Period | – | 65 days |
| Cash Conversion Cycle | – | 50 days |
Income Statement
| Metric | MLYS | OPK |
|---|---|---|
| Total Revenue | – | $638M |
| Operating Income | -$390M | -$128M |
| Net Income | -$370M | -$256M |
| R&D Expense | $293M | $127M |
| SG&A Expense | – | $177M |
| Cost of Goods Sold | – | $270M |
Dividend & Shareholder Information
| Metric | MLYS | OPK |
|---|---|---|
| Shares Outstanding | 88M | 746M |
MLYS vs OPK: stock comparison and AI forecast
Which is bigger, MLYS or OPK?
MLYS and OPK have similar market capitalizations ($1.35B and $1.31B).
Which one does Intratio's AI model rank higher, MLYS or OPK?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.